RecruitingPhase 2NCT05737121
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vaneltix Pharma, Inc.
- Intervention
- VNX001(drug)
- Enrollment
- 120 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (14)
- IC Study LLC, Escondido, California, United States
- University of California Los Angeles Center for Women's Pelvic Health, Los Angeles, California, United States
- The Clark Center for Urogynecology, Newport Beach, California, United States
- The Continence Center Medical Group, Inc dba Southern California Continence Center, Newport Beach, California, United States
- University of California San Diego Medical Center, San Diego, California, United States
- Prestige Medical Group, Tustin, California, United States
- United Research Institute, Hialeah, Florida, United States
- Florida Urology Partners, Tampa, Florida, United States
- Georgia Urology, Cartersville, Georgia, United States
- Southern Clinical Research Associates LLC, Metairie, Louisiana, United States
- Bay State Clinical Trials, Watertown, Massachusetts, United States
- Sheldon Freedman MD LTD, Las Vegas, Nevada, United States
- Northwell Health, Lake Success, New York, United States
- The Wake Forest Institute of Regenerative Medicine, Winston-Salem, North Carolina, United States
Collaborators
Prevail Infoworks
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05737121 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center